Literature DB >> 7559187

Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

M A Smith1, D I Edwards.   

Abstract

Metronidazole sensitive (MtzS) and resistant (MtzR) strains of Helicobacter pylori were tested for their sensitivities to eleven nitroheterocyclic drugs of known reduction potential under a wide range of environmental conditions. Under microaerophilic conditions, MtzR strains were sensitive to all the 2-nitroimidazoles, resistant to every 5-nitroimidazole, and slightly sensitive to the nitrothiazole, niridazole. MtzS strains were sensitive to all the nitroimidazoles except for 4(5)-nitroimidazole which has the lowest redox potential of all the drugs investigated. MtzS strains displayed the greatest sensitivity towards niridazole and satranidazole, the latter having the highest redox potential of the 5-nitroimidazoles. High and low oxygen tensions had no effect on the activity of the drugs but periods of anaerobic incubation caused resistant strains to become sensitive to the 5-nitroimidazoles. Superoxide dismutase and catalase were not induced by metronidazole and enzyme levels showed no correlation with resistance patterns. The results show that futile cycling does not occur in H. pylori and that the mechanism of action of the nitroimidazoles is related to their redox potential. Anaerobiosis abolishes resistance to metronidazole which suggests that it may be mediated through the activation of anaerobic metabolic pathways which function less under microaerophilic conditions or not at all.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559187     DOI: 10.1093/jac/35.6.751

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637.

Authors:  Y J Debets-Ossenkopp; R G Pot; D J van Westerloo; A Goodwin; C M Vandenbroucke-Grauls; D E Berg; P S Hoffman; J G Kusters
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.

Authors:  Vincenzo De Francesco; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Rosa Rosania; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

Review 3.  Nitroimidazoles for the treatment of TB: past, present and future.

Authors:  Tathagata Mukherjee; Helena Boshoff
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

4.  Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.

Authors:  J F Weel; R W van der Hulst; Y Gerrits; G N Tytgat; A van der Ende; J Dankert
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.

Authors:  P S Hoffman; A Goodwin; J Johnsen; K Magee; S J Veldhuyzen van Zanten
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.

Authors:  R W van der Hulst; A van der Ende; A Homan; P Roorda; J Dankert; G N Tytgat
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

Review 7.  Redox homeostasis in mycobacteria: the key to tuberculosis control?

Authors:  Ashwani Kumar; Aisha Farhana; Loni Guidry; Vikram Saini; Mary Hondalus; Adrie J C Steyn
Journal:  Expert Rev Mol Med       Date:  2011-12-16       Impact factor: 5.600

8.  A redox basis for metronidazole resistance in Helicobacter pylori.

Authors:  N O Kaakoush; C Asencio; F Mégraud; G L Mendz
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

9.  Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.

Authors:  Igor N Olekhnovich; Avery Goodwin; Paul S Hoffman
Journal:  FEBS J       Date:  2009-05-07       Impact factor: 5.542

10.  Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives.

Authors:  A T Axon
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.